This video summarizes the rationale for and controversies surrounding recommendations made by the Clinical Guidelines Committee of the American College of Physicians (ACP) in its 2018 Guidance Statement on hemoglobin A1c (HbA1c) targets for glycemic control with pharmacology therapy for nonpregnant adults with type 2 diabetes. Elizabeth L. Tung, MD, MS, and Neda Laiteerapong, MD, MS, both of the Chicago Center for Diabetes Translation Research in the Section of General Internal Medicine at the University of Chicago, explain.
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
You currently have no searches saved.
You currently have no courses saved.